225 related articles for article (PubMed ID: 18166997)
21. Impact on cardiac toxicity with trastuzumab and radiotherapy: the question is still ongoing.
Magné N; Védrine L; Chargari C
J Clin Oncol; 2009 Dec; 27(34):e239; author reply e240-1. PubMed ID: 19884526
[No Abstract] [Full Text] [Related]
22. Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?
Morabito A; Piccirillo MC; De Maio E; Di Maio M; Perrone F
J Clin Oncol; 2009 Sep; 27(27):e123; author reply e124-5. PubMed ID: 19687322
[No Abstract] [Full Text] [Related]
23. Cardiac effects of adjuvant therapy for early breast cancer.
Theodoulou M; Seidman AD
Semin Oncol; 2003 Dec; 30(6):730-9. PubMed ID: 14663774
[TBL] [Abstract][Full Text] [Related]
24. Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
Rowan K
J Natl Cancer Inst; 2009 Apr; 101(7):448-9. PubMed ID: 19318626
[No Abstract] [Full Text] [Related]
25. Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.
Wonders KY; Reigle BS
Integr Cancer Ther; 2009 Mar; 8(1):17-21. PubMed ID: 19174506
[TBL] [Abstract][Full Text] [Related]
26. Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.
Popat S; Smith IE
Nat Clin Pract Oncol; 2008 Jun; 5(6):324-35. PubMed ID: 18364726
[TBL] [Abstract][Full Text] [Related]
27. The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study.
Caussa L; Kirova YM; Gault N; Pierga JY; Savignoni A; Campana F; Dendale R; Fourquet A; Bollet MA
Eur J Cancer; 2011 Jan; 47(1):65-73. PubMed ID: 20843680
[TBL] [Abstract][Full Text] [Related]
28. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Petit T; Claude L; Carrie C
Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
[TBL] [Abstract][Full Text] [Related]
29. Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.
Ewer MS; Ewer SM
J Clin Oncol; 2010 Sep; 28(25):3901-4. PubMed ID: 20679626
[No Abstract] [Full Text] [Related]
30. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer.
Baselga J; Perez EA; Pienkowski T; Bell R
Oncologist; 2006; 11 Suppl 1():4-12. PubMed ID: 16971734
[TBL] [Abstract][Full Text] [Related]
31. Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter.
Morris PG; Hudis CA
Breast Cancer Res Treat; 2011 Jun; 127(2):585-6. PubMed ID: 18791822
[No Abstract] [Full Text] [Related]
32. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
Danilenko AA; Shakhtarina SV
Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
[No Abstract] [Full Text] [Related]
33. Trastuzumab versus lapatinib: the cardiac side of the story.
Azim H; Azim HA; Escudier B
Cancer Treat Rev; 2009 Nov; 35(7):633-8. PubMed ID: 19640652
[TBL] [Abstract][Full Text] [Related]
34. What is the risk of cardiac morbidity with adjuvant radiotherapy for breast cancer?
Vallis K
Nat Clin Pract Oncol; 2006 Apr; 3(4):180-1. PubMed ID: 16596139
[No Abstract] [Full Text] [Related]
35. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
36. Never use anthracyclines with trastuzumab: it is time to reconsider the taboo.
Gianni L
Breast Cancer Res Treat; 2009 Oct; 117(3):599-601. PubMed ID: 19387827
[No Abstract] [Full Text] [Related]
37. Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?
Verma N; Swain SM
J Clin Oncol; 2011 Feb; 29(6):603-6. PubMed ID: 21205751
[No Abstract] [Full Text] [Related]
38. Anthracyclines and breast radiotherapy: the need for prospective evaluation.
Madhavan KS; Pervez N
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):319-20; author reply 320. PubMed ID: 15093931
[No Abstract] [Full Text] [Related]
39. Controversies in the use of adjuvant trastuzumab (Herceptin).
Chowdhury S; Pickering L; Ellis P
J Br Menopause Soc; 2006 Dec; 12(4):172-4. PubMed ID: 17178019
[TBL] [Abstract][Full Text] [Related]
40. [Therapy concept: herceptin with anthracyclines].
Untch M
Onkologie; 2002 Dec; 25 Suppl 5():19-21; discussion 21. PubMed ID: 23573616
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
